Pain Management for Dental Medicine in 2021: Opioids, Coronavirus and Beyond
In collaboration with Tufts University School of Dental Medicine, Harvard School of Dental Medicine, and Massachusetts General Hospital

Saturday, April 10, 2021 from 8am – 4:15pm
Cost: Complimentary
Continuing Dental Education Credits: 7 lecture hours (optional 7.5 self-study hours)

Register Today Here!

Program Overview:

Over the past year our attention has inevitably been on the Coronavirus, the health of our families, patient and staff as well as the re-opening of our practices. However, the opioid crisis continues, is likely to worsen as a result of the Pandemic and continues to challenge Dentistry. We have brought together a group of national thought leaders and experts in this field who will share their insights on the current state of opioid prescribing in Dentistry and describe some of the exciting work being done in advancing pain management for our patients.

Program Agenda:

8:00 – 8:15 AM: Welcome and Introduction with Ronald J. Kulich, PhD

8:15 – 8:45 AM: First Keynote Speaker
Moderator: David A. Keith, BDS, FDSRCS, DMD, Professor, Oral and Maxillofacial Surgery, Harvard School of Dental Medicine, Visiting Oral and Maxillofacial Surgeon, Division of Oral and Maxillofacial Surgery, Department of Surgery, Massachusetts General Hospital

• Precision Medicine for Orofacial Pain Management by Christian Stohler, DMD, DrMedDent, Professor and Dean, Columbia University College of Dental Medicine, Senior Vice President for Dental Medicine Columbia University Medical Center

8:45 – 9:00 AM: Discussion

9:00 – 10:15 AM: Section 1: Opioids
Moderator: David A. Keith, BDS, FDSRCS, DMD

• The Controlled Substance Risk Assessment Program in Dentistry: Development, Barriers and Opportunities by Ronald J. Kulich, PhD, Professor, Tufts University School of Dental Medicine, Department of Diagnostic Sciences Lecturer, Department of Anesthesia, Critical Care and Pain Medicine/Department of Psychiatry, Massachusetts General Hospital
• Opioid Moderatism – Dental Implications by Michael E. Schatman, PhD, DAAPM, Clinical Associate, Department of Diagnostic Sciences, Tufts University School of Dental Medicine, Department of Public Health & Community Medicine, Tufts University School of Medicine, Editor-in-Chief Journal of Pain Research
• Opioid Sparing in Children and Adolescents by Cory Resnick, DMD, MD, Associate Professor of Oral & Maxillofacial Surgery, Harvard School of Dental Medicine and Harvard Medical School, Pediatric Craniomaxillofacial Surgeon, Department of Plastic and Oral Surgery, Boston Children’s Hospital

10:15 – 10:45 AM: Discussion

10:45 – 11:00 AM: Break

11:00 AM – 12:15 PM: Section 2: Coronavirus
Moderator: Michael E. Schatman, PhD, DAAPM

• Teledentistry – Its Use in Post COVID-19 Era by Mark Lerman, DMD, Professor and Chair, Department of Diagnostic Sciences, Chair, Division of Oral Pathology, Tufts University School of Dental Medicine
• Healthcare Disparities in Orofacial Pain by Nicole Holland, DMD, Professor Assistant, Director of Health Communication, Education and Promotion, Director of Public Health and Community Services, Tufts University School of Dental Medicine
• COVID-19 Effects on the Opioid Epidemic: Lessons Learned by Jenna McCauley, PhD, Assistant Professor, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina

12:15 – 12:45 PM: Discussion

12:45 – 1:15 PM: Lunch Break
*Register for optional Controlled Substance Risk Mitigation Education Modules for 7.5 CDE hours of self-study credit (see below for details)

1:15 – 2:30 PM: Section 3: And Beyond…
Moderator: Ronald J. Kulich, PhD

• ICOP Classification – The Good, The Bad, and The Indifferent by Shruti Handa, BDS, DMD, Orofacial Pain, Division of Oral and Maxillofacial Surgery, Department of Surgery, Massachusetts General Hospital, Instructor Harvard School of Dental Medicine
• Non-Opioid Medications and New Pharmacotherapy in the Pipeline by Lori Reisner, PharmD, FCSHP, Clinical Pharmacist, Neurological Surgery Department of Pharmaceutical Services, Clinical Professor of Pharmacy Department of Clinical Pharmacy, School of Pharmacy University of California, San Francisco Medical Center
• The Medical/Dental Intercept – Changing Attitudes in Dental Practice by R. Bruce Donoff, DMD, MD, Walter C. Guralnick Distinguished Professor of Oral and Maxillofacial Surgery, Harvard School of Dental Medicine, Harvard University Distinguished Service Professor and Former Dean, Harvard School of Dental Medicine Visiting Oral and Maxillofacial Surgeon, Massachusetts General Hospital

2:30 – 3:00 PM: Discussion

3:00 – 3:40 PM: Second Keynote Speaker
Moderator: Ronald J. Kulich, PhD

• Innovative Imaging Studies and More – What it Means for Orofacial Pain and Dental Medicine by Alex DaSilva, DDS, DMedSc, Associate Professor, Department of Biological and Material Sciences & Prosthodontics, Director and Founder, Headache and Orofacial Pain Lab, Co-Director, fNIRS Laboratory Center for Human Growth and Development Director, University of Michigan School of Dentistry Learning Health Systems, University of Michigan School of Dentistry

3:40 – 3:55 PM: Discussion

3:55 – 4:15 PM: Closing Remarks and Interactive Forum

Optional Self-Study Hours:

During the lunch break, participants will have the option to register for the following 10 free Controlled Substance Risk Mitigation Education modules. Each take about 45 min to complete and are worth .75 self-study credits each. You may also register and complete these in advance or after the conference:

• Module 1: Historical Overview of Dentistry’s Role in Assessing and Managing the Complex Patient at Risk for Substance Misuse
• Module 2: Interviewing the Patient: Strategies to Identify Substance Use Disorders, Including Opioid Misuse and Abuse
• Module 3: Special Screening Resources: Strategies to Identify Substance Use Disorders, Including Opioid Misuse and Abuse
• Module 4: Managing Acute Dental Pain: Principles for Rational Prescribing and Alternatives to Opioid Therapy
• Module 5: Medical and Psychiatric Conditions Associated with Increased Controlled Substance Risk
• Module 6: Assessment and Management of the High-Risk Dental Patient with Active Substance Use Disorder
• Module 7: Brief Motivational Interventions (MI): Strategies for Successful Management of the Complex, Non-Adherent Dental Patient
• Module 8: Special High-Risk Populations in Dentistry: The Adolescent Patient, the Elderly Patient, and the Woman of Childbearing Age
• Module 9: Interprofessional Collaboration and referral with Physicians and Mental Health/Addiction Medicine Specialists
• Module 10: Management Liability Risks in the Patient with Controlled Substance Misuse, while Pursing Responsible Opioid Prescribing